PaxVax, Inc.

PaxVax, Inc. is a specialty vaccine company based in Redwood City, California, founded in 2007.

The company is dedicated to developing, manufacturing, and commercializing innovative oral vaccines targeting infectious diseases that are often overlooked. PaxVax aims to provide financial returns through its travel vaccine business while also increasing global access to vaccines, particularly for developing nations. The company offers a range of oral vaccines, including Vivotif® for typhoid fever and Vaxchora® for cholera. PaxVax is also advancing several candidates in clinical development, such as vaccines for cholera, pandemic bird flu, and anthrax. Its primary customers include healthcare providers, international travelers, governments, and populations in developing countries. PaxVax operates R&D and manufacturing facilities in California and Switzerland and is majority-owned by an affiliate of Cerberus Capital Management.